The earnings call reflects a positive sentiment overall, as the company reported strong top line and adjusted EBITDA growth, raised its 2025 outlook, and continued to improve liquidity and leverage. Despite some challenges in specific segments such as Nelson Labs and Nordion, the overall performance and strategic investments indicate a robust financial health and growth trajectory.

Company Guidance -

Q3 2025

During the Sotera Health Second Quarter 2025 Earnings Call, the company provided an optimistic outlook for the remainder of the year, highlighting several key metrics and developments. Sotera Health reported a 6.4% increase in total revenue to $294 million, with adjusted EBITDA growing by 9.8% to $151 million. The adjusted EBITDA margin improved by 156 basis points to 51.2%. The company also raised its full-year 2025 revenue growth outlook to 4.5% to 6% and adjusted EBITDA growth to 6% to 7.5%. Segment-wise, Sterigenics experienced a 10.5% revenue growth driven by a favorable volume and mix contribution of 6%, while Nordion and Nelson Labs also reported positive results. Sotera Health continues to focus on disciplined financial management, evidenced by a reduction in net leverage from 3.7x at the end of 2024 to 3.5x in Q2 2025. Meanwhile, the effective tax rate applicable to adjusted net income is now projected to be in the range of 31.5% to 33.5%. Additionally, the company's adjusted EPS outlook has been increased to $0.75 to $0.82 per share. The call emphasized the company's commitment to long-term value creation, with ongoing investments in capacity expansion and optimization actions across its business segments.

Strong Top Line and Adjusted EBITDA Growth

Sotera Health's second quarter reported a top line growth of 6.4% and an adjusted EBITDA growth of 9.8%, with an improvement in adjusted EPS compared to the second quarter of 2024.

Sterigenics Revenue Growth

Sterigenics experienced a 10.5% year-over-year revenue growth, driven by increased customer demand, especially from core med device customers and bioprocessing.

Raising 2025 Outlook

Due to strong performance, Sotera Health raised its 2025 revenue growth outlook to 4.5% to 6% and adjusted EBITDA growth to 6% to 7.5%.

Nelson Labs Margin Expansion

Nelson Labs saw a margin expansion of more than 500 basis points, marking the fourth consecutive quarter of year-over-year margin improvement.

Improved Liquidity and Leverage

The company ended the second quarter with $918 million of available liquidity and improved its net leverage ratio to 3.5x from 3.7x at the end of 2024.

Sotera Health (SHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SHC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	0.22 / -	0.17	―	―	―
Aug 08, 2025	2025 (Q2)	0.17 / 0.20	0.19	5.26% (+0.01)
May 01, 2025	2025 (Q1)	0.12 / 0.14	0.13	7.69% (+0.01)
Feb 27, 2025	2024 (Q4)	0.20 / 0.21	0.26	-19.23% (-0.05)
Nov 05, 2024	2024 (Q3)	0.18 / 0.17	0.21	-19.05% (-0.04)
Aug 05, 2024	2024 (Q2)	0.17 / 0.19	0.21	-9.52% (-0.02)
May 02, 2024	2024 (Q1)	0.12 / 0.13	0.13	0.00% (0.00)
Feb 27, 2024	2023 (Q4)	0.26 / 0.26	0.25	4.00% (+0.01)
Nov 01, 2023	2023 (Q3)	0.20 / 0.21	0.23	-8.70% (-0.02)
Aug 03, 2023	2023 (Q2)	0.18 / 0.21	0.27	-22.22% (-0.06)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SHC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 08, 2025	$11.22	$13.97	+24.51%
May 01, 2025	$11.50	$12.10	+5.22%
Feb 27, 2025	$13.64	$12.28	-9.97%
Nov 05, 2024	$15.80	$15.42	-2.41%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sotera Health (SHC) report earnings?

Sotera Health (SHC) is schdueled to report earning on Nov 05, 2025, Before Open (Confirmed).

What is Sotera Health (SHC) earnings time?

Sotera Health (SHC) earnings time is at Nov 05, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SHC EPS forecast?

SHC EPS forecast for the fiscal quarter 2025 (Q3) is 0.22.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing